- Home
- AIRG vs ATRA Comparison
AIRG vs ATRA Comparison
Compare AIRG & ATRA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | AIRG | ATRA |
|---|---|---|
| Founded | 1995 | 2012 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Radio And Television Broadcasting And Communications Equipment | Biotechnology: Biological Products (No Diagnostic Substances) |
| Sector | Technology | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 47.4M | 38.9M |
| IPO Year | 2016 | 2014 |
Fundamental Metrics
Financial Performance| Metric | AIRG | ATRA |
|---|---|---|
| Price | $4.22 | $5.18 |
| Analyst Decision | Strong Buy | Hold |
| Analyst Count | 4 | 1 |
| Target Price | ★ $6.25 | $6.00 |
| AVG Volume (30 Days) | 45.1K | ★ 140.3K |
| Earning Date | 05-26-2026 | 01-01-0001 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 31.65 | N/A |
| EPS | N/A | ★ 2.93 |
| Revenue | $51,779,000.00 | ★ $128,940,000.00 |
| Revenue This Year | $13.17 | N/A |
| Revenue Next Year | $17.67 | N/A |
| P/E Ratio | ★ N/A | $1.71 |
| Revenue Growth | N/A | ★ 1404.02 |
| 52 Week Low | $3.00 | $3.92 |
| 52 Week High | $5.85 | $19.15 |
Technical Indicators
Market Signals| Indicator | AIRG | ATRA |
|---|---|---|
| Relative Strength Index (RSI) | 36.71 | 44.48 |
| Support Level | $3.96 | $4.06 |
| Resistance Level | $4.36 | $5.80 |
| Average True Range (ATR) | 0.33 | 0.53 |
| MACD | -0.14 | 0.31 |
| Stochastic Oscillator | 7.41 | 61.24 |
Price Performance
Historical ComparisonAbout AIRG Airgain Inc.
Airgain Inc is engaged in providing antenna technologies. These technologies can be used to enable performance wireless networking across devices and markets which include connected homes, enterprises, automotive, and the Internet of Things. It also provides solutions to complex radio frequency, engineering challenges, and improving wireless service that require higher throughput, broad coverage footprint, and carrier-grade quality. Geographically, it derives maximum revenue from North America and also has a presence in China and the Rest of the World. The company products include Antenna Plus: Fleet, M2M, IoT Antennas, Carrier-Class Antenna, Embedded Antennas, and External Dipole Antennas.
About ATRA Atara Biotherapeutics Inc.
Atara Biotherapeutics Inc operates in the United States healthcare sector. It focuses on developing transformative therapies for patients with serious diseases, including solid tumors, hematologic cancers, and autoimmune diseases. It operates and manages business as one operating and reportable segment which is the business of developing therapeutics. The company's product candidates comprise Tab-cel, ATA188, and ATA3219 (CAR T Platform).